Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
20.23
-6.26 (-23.63%)
At close: Feb 27, 2026, 4:00 PM EST
20.63
+0.40 (1.98%)
After-hours: Feb 27, 2026, 7:56 PM EST
Amphastar Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 719.89 | 712.81 | 593.24 | 498.99 | 437.77 | Upgrade
|
| Other Revenue | - | 19.15 | 51.16 | - | - | Upgrade
|
| Revenue | 719.89 | 731.97 | 644.4 | 498.99 | 437.77 | Upgrade
|
| Revenue Growth (YoY) | -1.65% | 13.59% | 29.14% | 13.98% | 25.13% | Upgrade
|
| Cost of Revenue | 363.83 | 358.11 | 290.57 | 250.13 | 238.03 | Upgrade
|
| Gross Profit | 356.06 | 373.86 | 353.82 | 248.86 | 199.74 | Upgrade
|
| Selling, General & Admin | 129.81 | 94.52 | 80.39 | 66.59 | 67.12 | Upgrade
|
| Research & Development | 85.84 | 73.91 | 73.74 | 74.77 | 60.93 | Upgrade
|
| Operating Expenses | 215.65 | 168.44 | 154.13 | 141.36 | 128.05 | Upgrade
|
| Operating Income | 140.4 | 205.42 | 199.69 | 107.5 | 71.69 | Upgrade
|
| Interest Expense | -25.48 | -35.34 | -33.06 | -1.85 | -0.89 | Upgrade
|
| Interest & Investment Income | 8.68 | 10.61 | 5.46 | 1.32 | 0.6 | Upgrade
|
| Earnings From Equity Investments | - | -0.57 | -1.98 | -1.18 | -0.21 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.02 | 9.08 | 1.97 | 9.07 | 13.54 | Upgrade
|
| EBT Excluding Unusual Items | 123.62 | 189.19 | 172.08 | 114.86 | 84.73 | Upgrade
|
| Asset Writedown | - | - | -2.7 | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | 1 | Upgrade
|
| Other Unusual Items | - | - | - | - | -1.8 | Upgrade
|
| Pretax Income | 123.62 | 189.19 | 169.38 | 114.86 | 83.93 | Upgrade
|
| Income Tax Expense | 25.53 | 29.67 | 31.83 | 23.48 | 20.63 | Upgrade
|
| Earnings From Continuing Operations | 98.09 | 159.52 | 137.55 | 91.39 | 63.3 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | -1.19 | Upgrade
|
| Net Income | 98.09 | 159.52 | 137.55 | 91.39 | 62.12 | Upgrade
|
| Net Income to Common | 98.09 | 159.52 | 137.55 | 91.39 | 62.12 | Upgrade
|
| Net Income Growth | -38.51% | 15.98% | 50.51% | 47.12% | 4327.37% | Upgrade
|
| Shares Outstanding (Basic) | 47 | 48 | 48 | 49 | 48 | Upgrade
|
| Shares Outstanding (Diluted) | 48 | 52 | 53 | 52 | 50 | Upgrade
|
| Shares Change (YoY) | -7.38% | -1.78% | 1.09% | 5.31% | 1.34% | Upgrade
|
| EPS (Basic) | 2.10 | 3.29 | 2.85 | 1.88 | 1.30 | Upgrade
|
| EPS (Diluted) | 2.03 | 3.06 | 2.60 | 1.74 | 1.25 | Upgrade
|
| EPS Growth | -33.66% | 17.69% | 49.43% | 39.20% | 4090.97% | Upgrade
|
| Free Cash Flow | 121.23 | 172.35 | 145.34 | 65.15 | 70.54 | Upgrade
|
| Free Cash Flow Per Share | 2.51 | 3.31 | 2.74 | 1.24 | 1.42 | Upgrade
|
| Gross Margin | 49.46% | 51.08% | 54.91% | 49.87% | 45.63% | Upgrade
|
| Operating Margin | 19.50% | 28.06% | 30.99% | 21.54% | 16.38% | Upgrade
|
| Profit Margin | 13.63% | 21.79% | 21.34% | 18.31% | 14.19% | Upgrade
|
| Free Cash Flow Margin | 16.84% | 23.54% | 22.55% | 13.06% | 16.11% | Upgrade
|
| EBITDA | 197.1 | 258.39 | 237.72 | 132.27 | 94.95 | Upgrade
|
| EBITDA Margin | 27.38% | 35.30% | 36.89% | 26.51% | 21.69% | Upgrade
|
| D&A For EBITDA | 56.7 | 52.97 | 38.04 | 24.77 | 23.27 | Upgrade
|
| EBIT | 140.4 | 205.42 | 199.69 | 107.5 | 71.69 | Upgrade
|
| EBIT Margin | 19.50% | 28.06% | 30.99% | 21.54% | 16.38% | Upgrade
|
| Effective Tax Rate | 20.65% | 15.68% | 18.79% | 20.44% | 24.58% | Upgrade
|
| Revenue as Reported | 719.89 | 731.97 | 644.4 | 498.99 | 437.77 | Upgrade
|
| Advertising Expenses | - | 10.5 | 10.4 | 8.7 | 8.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.